BIOLINK LIFE SCIENCES, INC. Patent applications |
Patent application number | Title | Published |
20130296390 | METHOD AND COMPOSITIONS FOR ENHANCING THE SAFETY OF ORALLY ADMINISTERED MAGNESIUM ALPHA-LIPOATE - The present invention relates to oral nutritional and therapeutic products which are useful for enhancing the safety of administering and reducing the adverse effects caused by magnesium alpha-lipoate to a warm-blooded mammal, comprising administering magnesium alpha-lipoate with D-biotin. | 11-07-2013 |
20120283320 | STABLE, WATER-INSOLUBLE R-(+)-ALPHA-LIPOIC ACID SALT USEFUL FOR THE TREATMENT OF DIABETES MELLITUS AND ITS CO-MORBIDITIES - The present invention relates to oral nutritional and therapeutic products which are useful for preventing or treating compensated and decompensated insulin resistance and associated diseases and sequelae, or diabetes mellitus and its sequelae, complications, and co-morbidities, comprising magnesium R-(+)-alpha-lipoate. | 11-08-2012 |
20110269837 | PHOSPHORUS BINDER COMPOSITION FOR TREATMENT OF HYPERPHOSPHATEMIA - The present invention relates to oral pharmaceutical products which are useful for binding phosphorus in ingesta, and inhibiting absorption of phosphorus from the gastrointestinal tract of subjects. A method for binding phosphorus in ingesta and inhibiting its absorption from the gastrointestinal tract is also provided. The pharmaceutical products and methods of the present invention are particularly useful in the treatment of hyperphosphatemia of chronic uremia and reducing serum phosphorus levels in patients requiring such therapy. | 11-03-2011 |
20110213022 | STABLE, WATER-INSOLUBLE R-(+)-ALPHA-LIPOIC ACID SALT USEFUL FOR THE TREATMENT OF DIABETES MELLITUS AND ITS CO-MORBIDITIES - The present invention relates to oral nutritional and therapeutic products which are useful for preventing or treating compensated and decompensated insulin resistance and associated diseases and sequelae, or diabetes mellitus and its sequelae, complications, and co-morbidities, comprising magnesium R-(+)-alpha-lipoate. | 09-01-2011 |
20110098347 | PHOSPHOROUS BINDER FOR TREATMENT OF KIDNEY DISEASE - The present invention relates to oral compositions which are useful for binding phosphorus in ingesta, and inhibiting absorption of phosphorus from the gastrointestinal tract of subjects. A method for binding phosphorus in ingesta and inhibiting its absorption from the gastrointestinal tract is also provided. The dietary supplements and pharmaceutical products and methods of the present invention are particularly useful in the treatment of hyperphosphatemia of chronic uremia and reducing serum phosphorus levels in patients requiring such therapy. | 04-28-2011 |